EverX Musculoskeletal Rehabilitation and Exercise Solution 'Mora' Wins CES Innovation Award

EverEx, a digital healthcare company specializing in musculoskeletal disorders, announced on the 21st that its rehabilitation and exercise therapy solution 'MORA' received the 'CES 2024 Innovation Awards' at CES 2024, the world's largest electronics and IT exhibition held in Las Vegas, USA, in January next year.

EverX's musculoskeletal rehabilitation and exercise therapy solution 'MORA' [Photo by EverX]

MORA, developed by EverEx, is an evidence-based personalized rehabilitation and exercise curriculum specialized for musculoskeletal disorder rehabilitation and exercise therapy. Utilizing cutting-edge artificial intelligence (AI) pose estimation technology, it analyzes patients' movements through a smartphone camera, enabling objective musculoskeletal assessments.

Rehabilitation and exercise therapy are the most highly evidence-based treatments recommended for musculoskeletal disorder care. MORA assigns appropriate rehabilitation exercises to patients through healthcare professionals and helps patients perform exercises at home or elsewhere via an application (app). It consists of a web platform for medical staff and an app for patients, allowing healthcare providers to offer timely feedback through data monitoring.

The rehabilitation and exercise curriculum of MORA was developed by a group of experienced specialists in orthopedics, psychiatry, and rehabilitation medicine based on medical evidence such as clinical research and treatment guidelines for disease management. It offers recommended treatment programs for over 150 musculoskeletal disorder conditions using a library of more than 10,000 rehabilitation and exercise modules.

Prior to receiving the CES 2024 Innovation Award, EverEx registered and launched the U.S. version of MORA, 'EverEx-Rehab,' as a Class II medical device with the U.S. Food and Drug Administration (FDA), targeting remote therapeutic monitoring (RTM) reimbursement. The solution is currently being supplied mainly to physical therapy centers in the U.S. The company plans to expand its supply following this award.

EverEx is also developing 'MORA-DTx,' a digital therapeutic device (DTx) based on MORA. Currently, multidisciplinary approaches such as cognitive behavioral therapy (CBT) for chronic pain in musculoskeletal disorders are recommended through treatment guidelines as they can improve patient adherence. Considering that patient adherence is crucial for activating DTx as well, EverEx is directly developing customized CBT specialized for disease characteristics and pain and integrating it into DTx. Clinical trials are underway for patellofemoral pain syndrome and chronic low back pain. Additionally, the AI-based solution 'MORA-Self' for musculoskeletal self-management among office workers is also set to be launched.

Yoon Chan, CEO of EverX [Photo by EverX]

Yoon Chan, CEO of EverEx, said, "After participating in CES for the first time last year, receiving the Innovation Award with MORA within a year is a great opportunity to reaffirm MORA's value through the world's largest event." He added, "MORA is a solution with clear demand from both patients and doctors, and we will do our best to activate musculoskeletal disorder rehabilitation and exercise both domestically and internationally through MORA." He continued, "The currently developing MORA-DTx is the first DTx in Korea and worldwide to combine rehabilitation exercise and cognitive behavioral therapy in the musculoskeletal disorder field. We will strive to develop and commercialize innovative solutions so that many musculoskeletal patients can receive full treatment through advanced technologies such as AI."

This content was produced with the assistance of AI translation services.